Search

Your search keyword '"Daneman, N."' showing total 418 results

Search Constraints

Start Over You searched for: Author "Daneman, N." Remove constraint Author: "Daneman, N."
418 results on '"Daneman, N."'

Search Results

2. Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study

10. Additional file 1 of Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings

11. Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

15. The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

16. The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

17. The economic burden of patient safety targets in acute care: a systematic review

18. Initial antimicrobial management of sepsis

19. The Effects of the Serious Illness Care Program (SICP) on Health Care Resource Utilization (HRU)

23. A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards.

24. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: Study protocol.

25. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management

26. Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000

28. Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions.

31. Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians.

32. Additional file 1: of Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings

33. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance

35. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

36. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance.

39. Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial

40. Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study

Catalog

Books, media, physical & digital resources